X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (42741) 42741
Magazine Article (73) 73
Newsletter (45) 45
Book Chapter (24) 24
Newspaper Article (22) 22
Publication (6) 6
Conference Proceeding (5) 5
Report (4) 4
Dissertation (3) 3
Government Document (3) 3
Book / eBook (2) 2
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (36997) 36997
female (25944) 25944
male (19503) 19503
cyclophosphamide - therapeutic use (18190) 18190
middle aged (17766) 17766
antineoplastic combined chemotherapy protocols - therapeutic use (17270) 17270
adult (16841) 16841
cyclophosphamide - administration & dosage (14870) 14870
cyclophosphamide (12861) 12861
oncology (11980) 11980
aged (11972) 11972
treatment outcome (7729) 7729
chemotherapy (7640) 7640
doxorubicin - administration & dosage (7326) 7326
vincristine - administration & dosage (6308) 6308
adolescent (6086) 6086
hematology (5638) 5638
animals (5564) 5564
combined modality therapy (5226) 5226
prognosis (5221) 5221
breast neoplasms - drug therapy (4887) 4887
cancer (4844) 4844
immunosuppressive agents - therapeutic use (4618) 4618
antineoplastic combined chemotherapy protocols - adverse effects (4467) 4467
cyclophosphamide - adverse effects (4435) 4435
child (4414) 4414
prednisone - therapeutic use (4346) 4346
therapy (4346) 4346
vincristine - therapeutic use (4326) 4326
prednisone - administration & dosage (3972) 3972
drug therapy, combination (3871) 3871
retrospective studies (3747) 3747
doxorubicin - therapeutic use (3641) 3641
antineoplastic combined chemotherapy protocols - administration & dosage (3578) 3578
follow-up studies (3538) 3538
antineoplastic agents - therapeutic use (3522) 3522
mice (3414) 3414
rituximab (3401) 3401
remission induction (3067) 3067
methotrexate - administration & dosage (3031) 3031
neoplasm staging (3024) 3024
time factors (3018) 3018
disease-free survival (2950) 2950
child, preschool (2888) 2888
drug administration schedule (2776) 2776
survival rate (2776) 2776
care and treatment (2731) 2731
transplantation (2691) 2691
aged, 80 and over (2650) 2650
etoposide - administration & dosage (2592) 2592
survival analysis (2589) 2589
cisplatin - administration & dosage (2504) 2504
methotrexate - therapeutic use (2484) 2484
breast cancer (2480) 2480
fluorouracil - administration & dosage (2473) 2473
doxorubicin (2329) 2329
survival (2325) 2325
breast neoplasms - pathology (2248) 2248
medicine & public health (2214) 2214
immunology (2145) 2145
young adult (1994) 1994
recurrence (1956) 1956
lymphoma, non-hodgkin - drug therapy (1940) 1940
chemotherapy, adjuvant (1935) 1935
prospective studies (1910) 1910
rheumatology (1908) 1908
dose-response relationship, drug (1856) 1856
clinical trials as topic (1840) 1840
medicine, general & internal (1829) 1829
pharmacology & pharmacy (1819) 1819
risk factors (1786) 1786
lymphoma, large b-cell, diffuse - drug therapy (1754) 1754
lung neoplasms - drug therapy (1722) 1722
trial (1691) 1691
research (1680) 1680
ovarian neoplasms - drug therapy (1640) 1640
infant (1625) 1625
analysis (1567) 1567
neoplasm metastasis (1537) 1537
bone marrow transplantation (1525) 1525
doxorubicin - adverse effects (1522) 1522
health aspects (1517) 1517
disease (1497) 1497
lymphomas (1474) 1474
prednisolone - therapeutic use (1437) 1437
biopsy (1409) 1409
azathioprine - therapeutic use (1390) 1390
fluorouracil - therapeutic use (1390) 1390
drug therapy (1370) 1370
non-hodgkins-lymphoma (1362) 1362
immunotherapy (1360) 1360
cisplatin (1359) 1359
hematopoietic stem cell transplantation (1325) 1325
cyclophosphamide - pharmacology (1312) 1312
methotrexate (1307) 1307
bleomycin - administration & dosage (1277) 1277
rats (1271) 1271
vincristine (1269) 1269
carcinoma (1265) 1265
pediatrics (1246) 1246
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (37328) 37328
Japanese (1519) 1519
German (1515) 1515
French (875) 875
Russian (646) 646
Chinese (513) 513
Spanish (450) 450
Italian (315) 315
Polish (264) 264
Hungarian (60) 60
Czech (58) 58
Dutch (44) 44
Portuguese (42) 42
Danish (31) 31
Romanian (28) 28
Croatian (25) 25
Bulgarian (20) 20
Hebrew (20) 20
Norwegian (19) 19
Serbian (17) 17
Swedish (17) 17
Ukrainian (17) 17
Slovak (15) 15
Finnish (11) 11
Turkish (6) 6
Lithuanian (4) 4
Bosnian (2) 2
Korean (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer Treatment Reviews, ISSN 0305-7372, 2014, Volume 40, Issue 9, pp. 1080 - 1088
Highlights • PTCL has a poor prognosis; existing therapies are insufficient. • We summarize current evidence on novel therapies for relapsed/refractory PTCL. •... 
Hematology, Oncology and Palliative Medicine | Antifolate | Nucleoside analog | Histone deacetylase inhibitor | Fusion protein | Peripheral T-cell lymphoma | Immunomodulatory agent | DENILEUKIN DIFTITOX | NON-HODGKINS-LYMPHOMAS | FOLLOW-UP | BRENTUXIMAB VEDOTIN SGN-35 | OPEN-LABEL | ALLOGENEIC TRANSPLANTATION | SINGLE-AGENT | PHASE-II TRIAL | ONCOLOGY | SALVAGE THERAPY | HIGH-DOSE CHEMOTHERAPY | Doxorubicin - therapeutic use | Humans | Recombinant Fusion Proteins - therapeutic use | Interleukin-2 - therapeutic use | Neoplasm Recurrence, Local - drug therapy | Antineoplastic Agents - therapeutic use | Cyclophosphamide - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Folic Acid Antagonists - therapeutic use | Stem Cell Transplantation | Topoisomerase Inhibitors - pharmacology | Thalidomide - analogs & derivatives | Diphtheria Toxin - therapeutic use | Topoisomerase Inhibitors - therapeutic use | Immunoconjugates - therapeutic use | Antineoplastic Agents - pharmacology | Depsipeptides - therapeutic use | Prednisolone - therapeutic use | Lymphoma, T-Cell, Peripheral - drug therapy | Antibodies, Monoclonal, Humanized - therapeutic use | Alemtuzumab | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Lymphoma, T-Cell, Peripheral - pathology | Vincristine - therapeutic use | Histone Deacetylase Inhibitors - therapeutic use | Lymphoma, T-Cell, Peripheral - therapy | Thalidomide - therapeutic use | Folic Acid Antagonists - pharmacology | Care and treatment | Lymphomas | T cells | Health aspects
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 10/2016, Volume 2016, Issue 10, p. CD003594
Journal Article
Medical Clinics of North America, ISSN 0025-7125, 05/2012, Volume 96, Issue 3, pp. 475 - 496
Over the past several decades, rheumatology has directed its focus to understanding and countering the immune dysregulation underlying autoimmune diseases with... 
Biologic response modifiers | Systemic lupus erythematosus | Vasculitis | Disease-modifying antirheumatic drugs | Biologics | Rheumatoid arthritis | SYSTEMIC-LUPUS-ERYTHEMATOSUS | RITUXIMAB THERAPY | 5-AMINOSALICYLIC ACID | REFRACTORY NEUROSARCOIDOSIS | ADENOSINE RECEPTORS | MEDICINE, GENERAL & INTERNAL | TUMOR-NECROSIS-FACTOR | COMBINATION TREATMENT | DOUBLE-BLIND | PLACEBO-CONTROLLED TRIAL | MYCOPHENOLATE-MOFETIL | Hydroxychloroquine - therapeutic use | Azathioprine - therapeutic use | Glucocorticoids - therapeutic use | Certolizumab Pegol | Rheumatic Diseases - drug therapy | Colchicine - therapeutic use | Humans | Recombinant Fusion Proteins - therapeutic use | Antibodies, Monoclonal - therapeutic use | Immunoglobulin Fab Fragments - therapeutic use | Methotrexate - therapeutic use | Polyethylene Glycols - therapeutic use | Cyclophosphamide - therapeutic use | Receptors, Tumor Necrosis Factor - therapeutic use | Abatacept | Etanercept | Infliximab | Minocycline - therapeutic use | Immunoconjugates - therapeutic use | Antirheumatic Agents - therapeutic use | Rheumatic Diseases - immunology | Sulfasalazine - therapeutic use | Antibodies, Monoclonal, Humanized - therapeutic use | Immunoglobulin G - therapeutic use | Rituximab | Cyclosporine - therapeutic use | Interleukin 1 Receptor Antagonist Protein - therapeutic use | Mycophenolic Acid - analogs & derivatives | Mycophenolic Acid - therapeutic use | Isoxazoles - therapeutic use | Adalimumab | Antibodies, Monoclonal, Murine-Derived - therapeutic use | Tumor Necrosis Factors - antagonists & inhibitors
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 05/2017, Volume 2019, Issue 10, p. CD003280
Background Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is a disease that causes progressive or relapsing and remitting weakness and... 
Immunologic Factors | Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | Chronic inflammatory demyelinating polyradiculopathy | Immunosuppressive Agents | Chronic inflammatory demyelinating polyradiculoneuropathy | Interferon beta‐1a | Treatment Outcome | Immunosuppressive and immunomodulatory treatment | Randomized Controlled Trials as Topic | Neurology | Interferon‐beta | Anti‐Inflammatory Agents | Azathioprine | Methotrexate | Medicine General & Introductory Medical Sciences | Immunoglobulins, Intravenous | Peripheral Neuropathy | SYSTEMIC-LUPUS-ERYTHEMATOSUS | Interferon-beta [therapeutic use] | Immunologic Factors [therapeutic use] | Humans | GUILLAIN-BARRE-SYNDROME | Immunosuppressive Agents [therapeutic use] | Anti-Inflammatory Agents [therapeutic use] | Azathioprine [therapeutic use] | RANDOMIZED CONTROLLED TRIAL | DISEASE-MODIFYING THERAPY | MEDICINE, GENERAL & INTERNAL | Interferon beta-1a | HIGH-DOSE CYCLOPHOSPHAMIDE | INTRAVENOUS IMMUNOGLOBULIN | Polyradiculoneuropathy, Chronic Inflammatory Demyelinating [drug therapy] | TERM-FOLLOW-UP | PLACEBO-CONTROLLED TRIAL | STEM-CELL TRANSPLANTATION | Methotrexate [therapeutic use] | MYCOPHENOLATE-MOFETIL | Interferon-beta - therapeutic use | Azathioprine - therapeutic use | Interferon beta-1a - therapeutic use | Immunoglobulins, Intravenous - therapeutic use | Immunosuppressive Agents - therapeutic use | Polyradiculoneuropathy, Chronic Inflammatory Demyelinating - drug therapy | Anti-Inflammatory Agents - therapeutic use | Methotrexate - therapeutic use | Immunologic Factors - therapeutic use
Journal Article
2005, Volume 6, Issue 2, 11
.... Since there are almost no randomized, controlled, double-blind studies comparing the use of various therapeutic agents in this condition, treatment decisions still rely heavily on individual clinicians experience... 
Methotrexate, therapeutic use | Mitomycin, therapeutic use | Tetracyclines, therapeutic use | Sulfasalazine, therapeutic use | Tacrolimus, therapeutic use | Nicotinamide, therapeutic use | Cyclophosphamide, therapeutic use | Mycophenolate mofetil, therapeutic use | Pemphigoid, treatment | Calcineurin inhibitors, therapeutic use | Azathioprine, therapeutic use | Leflunomide, therapeutic use | Immunoglobulins, therapeutic use | Interferon alpha 2b, therapeutic use | Corticosteroids, therapeutic use | Sulfapyridine, therapeutic use | Sulfamethoxypyridazine, therapeutic use | Thalidomide, therapeutic use | Ciclosporin, therapeutic use | Prednisone, therapeutic use | Pharmacotherapy | Medicine & Public Health | Pharmacology/Toxicology | Dermatology | PLASMA-EXCHANGE | IMMUNOSUPPRESSIVE THERAPY | TOPICAL CYCLOSPORINE | MITOMYCIN-C | PASSIVE TRANSFER | INTRAVENOUS IMMUNOGLOBULIN THERAPY | SYSTEMIC CHEMOTHERAPY | THALIDOMIDE THERAPY | NECROSIS-FACTOR-ALPHA | MYCOPHENOLATE-MOFETIL | DERMATOLOGY | Calcineurin Inhibitors | Pemphigoid, Benign Mucous Membrane - therapy | Antibiotics, Antineoplastic - therapeutic use | Immunoglobulins, Intravenous - therapeutic use | Mitomycin - therapeutic use | Humans | Immunosuppressive Agents - therapeutic use | Anti-Inflammatory Agents - therapeutic use | Adrenal Cortex Hormones - therapeutic use | Administration, Topical | Tetracyclines - therapeutic use | Plasmapheresis
Book Review
Journal of clinical oncology, ISSN 1527-7755, 2017, Volume 35, Issue 20, pp. 2260 - 2267
Journal Article
Blood, ISSN 1528-0020, 2019, Volume 133, Issue 18, pp. 1964 - 1976
Journal Article
Journal Article
Pediatric Drugs, ISSN 1174-5878, 2010, Volume 12, Issue 2, pp. 85 - 98
Hodgkin lymphoma is one of the few cancers that affect both adults and children. Cure rates for Hodgkin lymphoma remain among the best for pediatric cancers.... 
Anthracyclines, therapeutic use | Chlormethine, therapeutic use | Alkylating-agents, therapeutic use | Brentuximab-vedotin, therapeutic use | Cisplatin, therapeutic use | Bortezomib, therapeutic use | Bleomycin, therapeutic use | Children | Index Medicus
Journal Article